Cancer patient Debra Kantosky was offered the opportunity to participate in a clinical trial to determine if allowing patients to choose their own tobacco cessation treatment and level of coaching helps them quit.
Krystle Kuhs, professor in the Department of Epidemiology and Environmental Health in the College of Public Health, has been honored as a 2025-26 University Research Professor.
Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.
Weisi Yan presented his work on immunology-driven radiation oncology at the International Conference on Advances in Radiation Oncology in Vienna, Austria.
The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.
